Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.

Gross R, Yip B, Lo Re V 3rd, Wood E, Alexander CS, Harrigan PR, Bangsberg DR, Montaner JS, Hogg RS.

J Infect Dis. 2006 Oct 15;194(8):1108-14. Epub 2006 Sep 12.

2.
3.

Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.

Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR; Adolescent Medicine HIV/AIDS Research Network.

Arch Pediatr Adolesc Med. 2005 Aug;159(8):764-70.

PMID:
16061785
4.

Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.

Nolan S, Milloy MJ, Zhang R, Kerr T, Hogg RS, Montaner JS, Wood E.

AIDS Care. 2011 Aug;23(8):980-7. doi: 10.1080/09540121.2010.543882.

PMID:
21480010
5.

Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.

Wood E, Montaner JS, Yip B, Tyndall MW, Schechter MT, O'Shaughnessy MV, Hogg RS.

CMAJ. 2003 Sep 30;169(7):656-61.

6.
7.

Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.

Paredes R, Mocroft A, Kirk O, Lazzarin A, Barton SE, van Lunzen J, Katzenstein TL, Antunes F, Lundgren JD, Clotet B.

Arch Intern Med. 2000 Apr 24;160(8):1123-32.

PMID:
10789605
8.

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G.

Ann Intern Med. 2007 Apr 17;146(8):564-73.

PMID:
17438315
9.

Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-Infected patients in a population-based cohort.

Kuyper LM, Wood E, Montaner JS, Yip B, O'connell JM, Hogg RS.

J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1470-6.

PMID:
15602125
10.

A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.

Grossberg R, Zhang Y, Gross R.

J Clin Epidemiol. 2004 Oct;57(10):1107-10.

PMID:
15528063
11.

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, Montaner JS.

AIDS. 2002 May 3;16(7):1051-8.

PMID:
11953472
13.

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy.

Harrigan PR, Hogg RS, Dong WW, Yip B, Wynhoven B, Woodward J, Brumme CJ, Brumme ZL, Mo T, Alexander CS, Montaner JS.

J Infect Dis. 2005 Feb 1;191(3):339-47. Epub 2004 Dec 22.

14.

Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana.

Bisson GP, Rowh A, Weinstein R, Gaolathe T, Frank I, Gross R.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):107-10. doi: 10.1097/QAI.0b013e3181820141.

PMID:
18667926
15.

No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy.

Brumme ZL, Chan KJ, Dong WW, Mo T, Wynhoven B, Hogg RS, Montaner JS, O'Shaughnessy MV, Harrigan PR.

AIDS. 2002 Sep 27;16(14):1929-33.

PMID:
12351953
16.

Outpatient pharmacy care and HIV viral load response among patients on HAART.

Castillo E, Palepu A, Beardsell A, Akagi L, Yip B, Montaner JS, Hogg RS.

AIDS Care. 2004 May;16(4):446-57.

PMID:
15203413
17.

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load.

Gross R, Bilker WB, Friedman HM, Strom BL.

AIDS. 2001 Nov 9;15(16):2109-17.

PMID:
11684930
18.

Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.

Gifford AL, Bormann JE, Shively MJ, Wright BC, Richman DD, Bozzette SA.

J Acquir Immune Defic Syndr. 2000 Apr 15;23(5):386-95.

PMID:
10866231
19.

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN.

AIDS. 2003 Sep 5;17(13):1907-15.

PMID:
12960823
20.
Items per page

Supplemental Content

Write to the Help Desk